Global Postpartum Hemorrhage (PPH) Treatment Market by Application (Clinics, Hospitals, Other) by Type (Non-pneumatic Anti-shock Garment (NASG), Uterine Balloon Tamponade, Uniject Prefilled Injection System, Other) and By Region (Latin America, North America, Europe, Middle East, Asia Pacific and & Africa), Forecast To 2028  

Purchase Option

$ 4400
$ 6600
$ 8900

Global postpartum hemorrhage treatment market is evaluated to increase at Global at 5.10% CAGR during the forecast period 2018-2026.   Global Postpartum Hemorrhage Treatment Market Overview:   Postpartum hemorrhage is the regular form of obstetric hemorrhage. Postpartum hemorrhage is the also called as the vaginal blood loss in above than 500 ml following childbirth. When the loss of the blood occurs in the first 24 hours following delivery, it is called as primary postpartum hemorrhage. Pregnancy related problems occur due to the postpartum hemorrhage. The global postpartum hemorrhage treatment market analysis is a specific and thorough analysis of the medical device industry focusing mainly on global market trend. Detailed market segmentations is also provided by type and by end user. This report further provides key values of the market status of the prominent key players. This report also depicts opportunities and current trends and leading key players operating in the market.   Global Postpartum Hemorrhage Treatment Market – Key Drivers   Increasing pregnancy problems like inverted uterus, big size of the baby and multiple pregnancies are some key drivers of the market growth. Technological development like capability of the devices to soothe the patient’s condition until permanent treatment is given is propelling the market growth. Furthermore, different technological advances in the healthcare service provider industries in Asia Pacific are anticipated to provide growth opportunities for the market players working in the market. Increasing prevalence of postpartum hemorrhage is impelling the market growth. North America obtained the huge revenue share in the year 2017. Increasing government support and new product launchings by key players in the market are fuelling the market growth.   Global Postpartum Hemorrhage Treatment Market Segmentation:   The global postpartum hemorrhage treatment market has been segmented according to End User:   By End user

  • Hospitals & Clinics
  • Nursing Center
  • Others
  The global postpartum hemorrhage treatment market has been segmented according to type:
  • Uniject Prefilled Injection System
  • Uterine Balloon Tamponade
  • Non-Pneumatic Anti Shock Garment
  Geographically, the global postpartum hemorrhage treatment market has been segmented according to region: North America
  • U.S.
  • Canada
Asia Pacific Market
  • China
  • India
  • Japan
  • South Korea
 Europe
  • UK
  • France
  • Germany
  • Spain
  • Italy
Rest of World
  • Latin America
  • Middle East
  • North Africa
  • Rest of Africa
  North America is projected to account for the huge market revenue share. Postpartum hemorrhage treatment market in the region is driven by the growing maternal mortality rate and growing pregnancy complications. A major challenge for the market in the region is lack of skilled healthcare providers. A few other key factors impelling the market growth in North America are superior hospital deliver rates, increasing alertness amid patients and viable accessibility of treatment devices. Asia pacific is also anticipated to be key market for postpartum hemorrhage treatment. The increasing occurrence of postpartum hemorrhage cases throughout the Asia Pacific is a key factor to drive the market growth in the region. Europe is anticipated to record huge growth because of the huge population having the history of adverse preeclampsia, anemia and anticoagulant medication. Higher hospital birth rates, favorable government policies, huge awareness amid patients and high hospital birth rate impel the Europe postpartum hemorrhage market.   Competitive Analysis:   Below is given the list of key players operating in the market:
  • Cook Medical, Inc.
  • BARD, A Becton, Dickinson Company
  • Utah Medical Products, Inc.
  • Zoex NIASG
  • Becton, Dickinson and Company
  • Bactiguard
  Increasing pregnancy complications like upturned uterus, numerous pregnancies and big size of the baby will drive the market growth. This market report does the analysis of drivers, restraints, future trends and opportunities. It also gives comprehensive PEST analysis for the major regions like Europe, North America, MEA, Europe and APAC. This report also covers political, social, technological and economic factors affecting the market in all these regions.    

Location

GEOGRAPHY

PBI Location Map

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Adjacent Markets